ULZIIBAT PERSON: Open Payments
NPI 1831607969 · HILO, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 6 payments from 3 companies in 2025. Trend: 2023 $178 · 2024 $33 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $461 |
| Otsuka America Pharmaceutical, Inc. | 2 | $284 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
Products named: INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, UZEDY.
Industry payments across HI — which companies pay providers there.
